Status:
COMPLETED
Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18-95 years
Brief Summary
The purpose of this study was to identify the prognostic factors of affecting pT4bN0M0 colorectal cancer patients, so as to better stratify the prognostic differences among patients with the same stag...
Detailed Description
Patients with pT4b stage colorectal cancer (CRC) are a complex and special group due to the diversity of infiltrated organs, patients with the same stage often have different prognosis after multivisc...
Eligibility Criteria
Inclusion
- The patient was pathologically diagnosed as colorectal adenocarcinoma.
- Patients with pT4bN0M0 colorectal cancer.
- Patients with R0 resection.
Exclusion
- Patients with distant metastasis.
- Patients with R1 or R2 resection.
- Patients with lymph node metastasis
- Recurrent colorectal cancer.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 26 2023
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT06115837
Start Date
September 1 2023
End Date
September 26 2023
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China, 100021